Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1
- PMID: 38863793
- PMCID: PMC11165433
- DOI: 10.1093/discim/kyae006
Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1
Abstract
Despite extensive regulatory T cell (Treg) research, fundamental questions on in vivo dynamics remain to be answered. The current study aims to dissect several interwoven concepts in Treg biology, highlighting the 'self-reactivity' of Treg and their counterparts, namely naturally-arising memory-phenotype T-cells, as a key mechanism to be exploited by a human retroviral infection. We propose the novel key concept, Periodic T cell receptor (TCR)-signalled T-cells, capturing self-reactivity in a quantifiable manner using the Nr4a3-Timer-of-cell-kinetics-and-activity (Tocky) technology. Periodic and brief TCR signals in self-reactive T-cells contrast with acute TCR signals during inflammation. Thus, we propose a new two-axis model for T-cell activation by the two types of TCR signals or antigen recognition, elucidating how Foxp3 expression and acute TCR signals actively regulate Periodic TCR-signalled T-cells. Next, we highlight an underappreciated branch of immunological research on Human T-cell Leukemia Virus type 1 (HTLV-1) that precedes Treg studies, illuminating the missing link between the viral infection, CD25, and Foxp3. Based on evidence by single-cell analysis, we show how the viral infection exploits the regulatory mechanisms for T-cell activation and suggests a potential role of periodic TCR signalling in infection and malignant transformation. In conclusion, the new perspectives and models in this study provide a working framework for investigating Treg within the self-reactive T-cell spectrum, expected to advance understanding of HTLV-1 infection, cancer, and immunotherapy strategies for these conditions.
Keywords: Foxp3; HTLV-1; Nr4a3; T cell receptor signalling; Tocky; memory-phenotype T-cells; regulatory T-cells; self-reactive T-cells.
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Immunology.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





References
Publication types
LinkOut - more resources
Full Text Sources